Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study
- García-Sáenz, J.A.
- Marmé, F.
- Untch, M.
- Bonnefoi, H.
- Kim, S.-B.
- Bear, H.
- Mc Carthy, N.
- Gelmon, K.
- Martin, M.
- Kelly, C.M.
- Reimer, T.
- Toi, M.
- Law, E.
- Bhattacharyya, H.
- Gnant, M.
- Makris, A.
- Seiler, S.
- Burchardi, N.
- Nekljudova, V.
- Loibl, S.
- Rugo, H.S.
Revue:
European Journal of Cancer
ISSN: 1879-0852, 0959-8049
Année de publication: 2024
Volumen: 196
Type: Article